I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

Relative Value

The Relative Value of one FLERIE stock under the Base Case scenario is 0.01 SEK. Compared to the current market price of 45 SEK, InDex Pharmaceuticals Holding AB is Overvalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FLERIE Relative Value
Base Case
0.01 SEK
Overvaluation 100%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
7
Median 3Y
19.5
Median 5Y
33 707.1
Industry
2.6
vs History
vs Industry
Median 3Y
-74.2
Median 5Y
-126.8
Industry
22.3
Forward
-90.9
vs History
vs Industry
Median 3Y
-61.4
Median 5Y
-126.1
Industry
17.5
vs History
vs Industry
Median 3Y
-60.9
Median 5Y
-123.7
Industry
24.8
vs History
95
vs Industry
4
Median 3Y
17.3
Median 5Y
23.6
Industry
2.1
vs History
47
vs Industry
7
Median 3Y
16.1
Median 5Y
24 892.1
Industry
2.7
vs History
vs Industry
Median 3Y
-55.3
Median 5Y
-337.5
Industry
5.3
vs History
vs Industry
Median 3Y
-71.5
Median 5Y
-119
Industry
13.4
Forward
-10.3
vs History
vs Industry
Median 3Y
-70.7
Median 5Y
-117.4
Industry
16.8
Forward
-10.3
vs History
vs Industry
Median 3Y
-58
Median 5Y
-120.8
Industry
15.9
vs History
vs Industry
Median 3Y
-58
Median 5Y
-120.8
Industry
18.5
vs History
46
vs Industry
Median 3Y
-99.1
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

FLERIE Competitors Multiples
InDex Pharmaceuticals Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
InDex Pharmaceuticals Holding AB
STO:FLERIE
3.5B SEK 35 129.9 -18.5 -11 -11
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
788.6B USD 20.3 107.4 53.8 60.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
384.8B USD 4.4 26.2 12.6 16.5
US
Merck & Co Inc
NYSE:MRK
259.4B USD 4.2 18.9 12.8 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.3 170.5 255.6
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
160.4B USD 2.7 37.7 11 16.7
P/E Multiple
Earnings Growth
SE
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Average P/E: 36.7
Negative Multiple: -18.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
107.4
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.5
89%
US
Johnson & Johnson
NYSE:JNJ
26.2
-22%
US
Merck & Co Inc
NYSE:MRK
18.9
7 426%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
AstraZeneca PLC
LSE:AZN
34.3
175%
CH
Novartis AG
SIX:NOVN
13.1
19%
US
Pfizer Inc
NYSE:PFE
37.7
712%

See Also

Discover More
Back to Top